Navidea Biopharmaceuticals Inc (NAVB)
0.0382
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Navidea Biopharmaceuticals 1 Year Total Returns (Daily): -80.44% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -80.44% |
May 02, 2024 | -82.67% |
May 01, 2024 | -84.78% |
April 30, 2024 | -86.26% |
April 29, 2024 | -86.65% |
April 26, 2024 | -84.12% |
April 25, 2024 | -84.96% |
April 24, 2024 | -85.00% |
April 23, 2024 | -85.60% |
April 22, 2024 | -82.78% |
April 19, 2024 | -86.54% |
April 18, 2024 | -86.74% |
April 17, 2024 | -84.43% |
April 16, 2024 | -88.16% |
April 15, 2024 | -86.15% |
April 12, 2024 | -84.31% |
April 11, 2024 | -85.69% |
April 10, 2024 | -85.38% |
April 09, 2024 | -85.02% |
April 08, 2024 | -82.55% |
April 05, 2024 | -84.68% |
April 04, 2024 | -81.95% |
April 03, 2024 | -85.65% |
April 02, 2024 | -85.67% |
April 01, 2024 | -87.31% |
Date | Value |
---|---|
March 28, 2024 | -86.96% |
March 27, 2024 | -87.75% |
March 26, 2024 | -87.55% |
March 25, 2024 | -85.17% |
March 22, 2024 | -86.98% |
March 21, 2024 | -87.35% |
March 20, 2024 | -83.53% |
March 19, 2024 | -87.88% |
March 18, 2024 | -88.76% |
March 15, 2024 | -87.92% |
March 14, 2024 | -85.41% |
March 13, 2024 | -85.58% |
March 12, 2024 | -88.43% |
March 11, 2024 | -89.68% |
March 08, 2024 | -87.81% |
March 07, 2024 | -87.60% |
March 06, 2024 | -88.09% |
March 05, 2024 | -90.08% |
March 04, 2024 | -89.50% |
March 01, 2024 | -87.33% |
February 29, 2024 | -85.40% |
February 28, 2024 | -85.48% |
February 27, 2024 | -87.40% |
February 26, 2024 | -87.24% |
February 23, 2024 | -84.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.76%
Minimum
Jun 06 2023
800.0%
Maximum
Aug 03 2020
-5.11%
Average
-65.24%
Median
Apr 28 2020
1 Year Total Returns (Daily) Benchmarks
Perspective Therapeutics Inc | 196.0% |
Electromed Inc | 78.40% |
Xtant Medical Holdings Inc | 41.62% |
Asensus Surgical Inc | -62.34% |
Senseonics Holdings Inc | -14.09% |